The legacy of Viagra and its impact on the drug landscape presents a thorny question for shareholders . Initially a blockbuster drug, copycat medications have significantly diminished its market presence , creating obstacles for companies participating to the original patent holder and subsequent formulas. While some firms might gain from specializ